QTc Prolongation Risk Evaluation in Female COVID-19 Patients Undergoing Chloroquine and Hydroxychloroquine With/Without Azithromycin Treatment

Women have higher risk for developing TdP in response to ventricular repolarization prolonging drugs. Hundreds of trials are administering chloroquine and hydroxychloroquine with/without azithromycin to COVID-19 patients. While an overall prolonged QTc has been reported in COVID-19 patients undergoi...

Descripción completa

Detalles Bibliográficos
Autores principales: Grewal, Sarah, Jankelson, Lior, van den Broek, Marcel P. H., Cour, Martin, Bachmann, Gloria, Kostis, John B., Misra, Kamana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498717/
https://www.ncbi.nlm.nih.gov/pubmed/33102533
http://dx.doi.org/10.3389/fcvm.2020.00152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498717/
https://www.ncbi.nlm.nih.gov/pubmed/33102533
http://dx.doi.org/10.3389/fcvm.2020.00152

Ejemplares similares